Elnas, Emelda S.
HRN: 17-08-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2023
CEFUROXIME 750MG (VIAL)
05/12/2023
05/17/2023
IV
1.5g
Q8
S/p Cholecystectomy
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes